Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Birt-Hogg-Dubé syndrome: a case report and a review of the literature.

Jensen DK, Villumsen A, Skytte AB, Madsen MG, Sommerlund M, Bendstrup E.

Eur Clin Respir J. 2017 Feb 20;4(1):1292378. doi: 10.1080/20018525.2017.1292378. eCollection 2017 Feb 20. Review.

2.

Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

Gaur S, Turkbey B, Choyke P.

Semin Ultrasound CT MR. 2017 Feb;38(1):59-71. doi: 10.1053/j.sult.2016.10.002. Epub 2016 Oct 14.

PMID:
28237281
3.

Birt-Hogg-Dube syndrome prospectively detected by review of chest computed tomography scans.

Park HJ, Park CH, Lee SE, Lee GD, Byun MK, Lee S, Lee KA, Kim TH, Kim SH, Yang SY, Kim HJ, Ahn CM.

PLoS One. 2017 Feb 2;12(2):e0170713. doi: 10.1371/journal.pone.0170713. eCollection 2017 Feb 2.

4.

Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma.

Prokopowicz G, Życzkowski M, Nowakowski K, Bogacki R, Bryniarski P, Paradysz A.

Biomed Res Int. 2016;2016:8687575. doi: 10.1155/2016/8687575. Epub 2016 Dec 26.

5.

Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.

Li T, Ning X, He Q, Gong K.

Chin J Cancer. 2017 Jan 9;36(1):4. doi: 10.1186/s40880-016-0172-5.

6.

A rare cause of cystic lung disease - Birt-Hogg-Dubé syndrome.

Minnis P, Riddell P, Keane MP.

Respir Med Case Rep. 2016 May 29;18:90-2. doi: 10.1016/j.rmcr.2016.05.007. eCollection 2016 May 29.

7.

Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.

Dong L, Gao M, Hao WJ, Zheng XQ, Li YG, Li XL, Yu Y.

Medicine (Baltimore). 2016 May;95(22):e3695. doi: 10.1097/MD.0000000000003695.

8.

Birt-Hogg-Dubé syndrome detected incidentally by asymptomatic bilateral pneumothorax in health screening: a case of a young Japanese woman.

Miura K, Kondo R, Kurai M, Ishii K.

Surg Case Rep. 2015 Dec;1(1):17. doi: 10.1186/s40792-015-0014-8. Epub 2015 Feb 18.

9.

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries.

Bratslavsky G, Woodford MR, Daneshvar M, Mollapour M.

Oncotarget. 2016 Mar 29;7(13):15292-8. doi: 10.18632/oncotarget.7733.

10.

Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

Stratton KL, Alanee S, Glogowski EA, Schrader KA, Rau-Murthy R, Klein R, Russo P, Coleman J, Offit K.

Urol Oncol. 2016 May;34(5):238.e1-7. doi: 10.1016/j.urolonc.2015.11.021. Epub 2015 Dec 23.

PMID:
26723226
11.

Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.

Schmidt LS, Linehan WM.

Expert Opin Orphan Drugs. 2015;3(1):15-29. Epub 2014 Nov 29.

12.

Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Yap NY, Rajandram R, Ng KL, Pailoor J, Fadzli A, Gobe GC.

Biomed Res Int. 2015;2015:476508. doi: 10.1155/2015/476508. Epub 2015 Sep 13. Review.

13.

Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.

Näf E, Laubscher D, Hopfer H, Streit M, Matyas G.

Fam Cancer. 2016 Jan;15(1):127-32. doi: 10.1007/s10689-015-9837-5.

14.

Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Schmidt LS, Linehan WM.

Nat Rev Urol. 2015 Oct;12(10):558-69. doi: 10.1038/nrurol.2015.206. Epub 2015 Sep 1. Review.

15.

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.

Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, Strande NT, Weck KE, Wilhelmsen KC, Evans JP.

Genet Med. 2016 May;18(5):467-75. doi: 10.1038/gim.2015.104. Epub 2015 Aug 13.

16.

Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.

Benusiglio PR, Giraud S, Deveaux S, Méjean A, Correas JM, Joly D, Timsit MO, Ferlicot S, Verkarre V, Abadie C, Chauveau D, Leroux D, Avril MF, Cordier JF, Richard S; French National Cancer Institute Inherited Predisposition to Kidney Cancer Network..

Orphanet J Rare Dis. 2014 Oct 29;9:163. doi: 10.1186/s13023-014-0163-z.

17.

Nephron-sparing surgery for multifocal and hereditary renal tumors.

Metwalli AR, Linehan WM.

Curr Opin Urol. 2014 Sep;24(5):466-73. doi: 10.1097/MOU.0000000000000094. Review.

18.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM.

Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2. Review.

19.

Bilateral renal tumour as indicator for birt-hogg-dubé syndrome.

Johannesma PC, van Moorselaar RJ, Horenblas S, van der Kolk LE, Thunnissen E, van Waesberghe JH, Menko FH, Postmus PE.

Case Rep Med. 2014;2014:618675. doi: 10.1155/2014/618675. Epub 2014 Mar 20.

20.

Two Japanese cases of birt-hogg-dubé syndrome with pulmonary cysts, fibrofolliculomas, and renal cell carcinomas.

Murakami Y, Wataya-Kaneda M, Tanaka M, Takahashi A, Tsujimura A, Inoue K, Nonomura N, Katayama I.

Case Rep Dermatol. 2014 Feb 7;6(1):20-8. doi: 10.1159/000358216. eCollection 2014 Feb 7.

Supplemental Content

Support Center